Tivity Health (TVTY) Looks Good: Stock Adds 6.2% in Session
Tivity Health, Inc. TVTY was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 43.6% in the past one-month time frame.
The company has seen five positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Tivity Health. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Tivity Health currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Tivity Health, Inc. Price
Investors interested in the Medical - Services industry may consider LHC Group, Inc. LHCG, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is TVTY going up? Or down? Predict to see what others think:Up or Down
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Click to get this free report
LHC Group, Inc. (LHCG): Free Stock Analysis Report
Healthways, Inc. (TVTY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.